Prime Minister Narendra Modi described the Genome India Project as a pivotal development in the biotechnology sector and an essential component of the foundation for achieving the vision of ‘Viksit Bharat’ (Developed India). Speaking via video message on Thursday, he outlined the significance of the initiative in advancing biotechnology in India.
The Prime Minister said that the project, approved five years ago, had been completed despite challenges posed by the Covid-19 pandemic. He commended scientists for their work and acknowledged the contributions of over 20 research institutions, including IISc, IITs, CSIR, and DBT-BRIC. The project has culminated in the genome sequencing of 10,000 Indians, with the data now accessible at the Indian Biological Data Centre.
PM Modi highlighted that the Genome India Project represents a key milestone for biotechnology research in India. He added that the availability of genetic data would support scientists and researchers in understanding the genetic landscape of the Indian population.
He emphasized the significance of understanding genetic identity to address region-specific medical challenges. Referencing the issue of sickle cell anemia in tribal communities, Modi noted that genetic studies are crucial for creating targeted treatments and solutions.
The Prime Minister further remarked on the growth of India’s bio-economy, which has expanded from $10 billion in 2014 to over $150 billion. The recent launch of the Bio E3 Policy is intended to boost India’s position in the global biotechnology sector. Modi stated that the policy aims to build on this momentum, comparable to the impact of the IT revolution.
